Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter

Investor News

Clinical Development News
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
Approvable Letters
Approval and Marketing Clearance
Recalls and Warnings

Deals & Dollars News
Earnings Reports
Mergers and Acquisitions

IPO News

Clinical - BLA/NDA/ANDA
FDA Panel Denies Clarus Therapeutics' Oral Testosterone Drug Rextoro 9/18/2014 4:15:54 PM
Jaguar Animal Health, Inc. Files Eighth Investigational New Animal Drug Application 9/17/2014 11:05:46 AM
Salix Pharmaceuticals, Ltd. (SLXP) Release: UCERIS® (budesonide) 2mg Rectal Foam For The Induction Of Remission Of Mild-To-Moderate Distal Ulcerative Colitis Granted Tentative Approval By FDA 9/16/2014 8:49:54 AM
FDA Panel Recommends Approval Of NPS Pharmaceuticals, Inc. (NPSP)'s Natpara To Treat Hypoparathyroidism 9/12/2014 3:44:50 PM
Vernalis PLC (VNLPY.PK) Release: FDA Accepts Tuzistra™ XR (CCP-01) NDA For Full Review 9/15/2014 8:30:40 AM
Shire Announces FDA Acceptance For Filing With Priority Review Of Supplemental New Drug Application (sNDA) for Vyvanse® (lisdexamfetamine dimesylate) Capsules (CII) For Adults With Binge Eating Disorder 9/15/2014 8:52:13 AM
Novo Nordisk A/S (NVO)'s Liraglutide Safe, Effective For Obesity: FDA Panel 9/12/2014 6:02:28 AM
FDA Initial Briefs Find Novo Nordisk A/S (NVO)'s Liraglutide Effective 9/10/2014 6:33:22 AM
FDA Staff Review Of NPS Pharmaceuticals, Inc. (NPSP) Drug Natpara Sparks Stock Rebound 9/10/2014 3:33:06 PM
Actavis (ACT) Blood Pressure Pill Not Backed By FDA Advisers 9/10/2014 6:41:48 AM
NPS Pharmaceuticals, Inc. (NPSP) Release: FDA Posts Briefing Materials For Advisory Committee Meeting Reviewing Natpara® For Hypoparathyroidism 9/10/2014 10:55:03 AM
Relmada Therapeutics Announces The Filing Of Clinical Trial Application In Canada For d-methadone 9/10/2014 7:49:10 AM
Orexigen Therapeutics, Inc. (OREX), Novo Nordisk A/S (NVO) Seek To Enter Still Struggling Obesity Market This Week 9/9/2014 6:44:20 AM
Opko Health, Inc. Licensee Tesaro, Inc. (TSRO) Submits New Drug Application for Rolapitant 9/8/2014 12:28:41 PM
Gilead Sciences, Inc. (GILD) Release: First-Line Combination Of Ambrisentan And Tadalafil Reduces Risk Of Clinical Failure Compared To Monotherapy In Pulmonary Arterial Hypertension Outcomes Study 9/8/2014 10:52:13 AM